Search Results

Litigation doesn’t have to mean waiting years for resolution. By monetizing a strong antitrust claim, a Fortune 100 company secured $75 million in immediate cash while preserving the upside of its litigation—and without altering its existing fee arrangements.

By monetizing a pending antitrust claim, a regional retail company accessed $10 million in liquidity to rebrand its stores and drive revenue — all without giving up control or future upside from the claim.

London remains a leading global hub for commercial disputes, driven by the strength of English law and its appeal to international litigants. In this webcast, experts from Burford Capital, Portland Communications and Clifford Chance discuss how London can stay competitive amid rising global alternatives by adapting to evolving client needs around cost, speed and enforceability.

In this video, Craig Arnott and Charlie Rooke reflect on ten years of the UK’s opt-out collective actions regime, highlighting the central role of legal finance in enabling complex competition claims and delivering effective redress.

Ahead of INSOL in London, the conversations we are having with corporates, insolvency and restructuring professionals are increasingly focused on a common set of pressures: Rising input costs, tightening liquidity and a more constrained financing environment, often all hitting at once.

Given growing interest in legal finance in India, Quentin Pak asked a group of international lawyers from leading Indian law firms to address the legal framework regulating funding, recent monetization activity and predictions for the future of legal finance in the region.

Burford pioneered portfolio financing, making the first publicly announced law firm portfolio arrangement in 2011. Since then, appetite for portfolio financing solutions has dramatically increased.

Experts and non-experts alike predicted a wave of bankruptcies and insolvencies following the business disruption caused by Covid-19 in 2021. However, new filings globally were much lower than expected following historic levels of government support and easy access to cheap liquidity in the capital markets. Despite this, we expect new commercial filings to pick back up as government support around the world abates.

In April 2021, Andrew Cohen directed questions concerning the most salient industry forces and the most high-value disputes in the health care sector to a respected group of law firm leaders. Download the Quarterly to learn more.

The disruption of 2020 presented one of the biggest and most important challenges to the biotech and pharmaceutical industries. Learn how the pandemic has led to a reevaluation of investment in R&D, an increased interest in parallel therapies and an evolution in how companies manage associated legal risks.

In a panel with Burford CFO Jim Kilman, finance professionals share how they think about litigation assets and affirmative recovery programs.